Ptc Therapeutics (PTCT) EBT Margin Growth (5y) (2017 - 2026)

Ptc Therapeutics (PTCT) EBT Margin Growth (5y) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Ptc Therapeutics 6.47 Bn 4.58 Bn 244.52 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10,779.00
Dec 31, 2025 -44,877.00
Sep 30, 2025 2,910.00
Jun 30, 2025 20,130.00
Mar 31, 2025 24,382.00
Dec 31, 2024 3,394.00
Sep 30, 2024 3,475.00
Mar 31, 2024 9,453.00
Dec 31, 2023 -2,255.00
Sep 30, 2023 1,071.00
Jun 30, 2023 148,247.00
Mar 31, 2023 -2,724.00
Dec 31, 2022 -11,910.00
Sep 30, 2022 2,171.00
Jun 30, 2022 -5,366.00
Mar 31, 2022 2,731.00
Dec 31, 2021 3.66 Mn
Sep 30, 2021 349,904.00
Jun 30, 2021 1.98 Mn
Mar 31, 2021 10,912.00